Psilocybin, a prodrug of psilocin found in magic mushrooms, has garnered significant attention as a potential rapid-acting antidepressant when delivered in the form of psilocybin-assisted therapy. The existing evidence is undoubtedly promising, but far from conclusive, as previous studies were limited by their design, small sample sizes, or were conducted in a depressed population in the context…
